Kelli D. Allen, S. Sam Lim
doi : 10.1002/acr.25062
William Daniel Soulsby, Erica Lawson, Matthew S. Pantell
doi : 10.1002/acr.24991
Health disparities in juvenile idiopathic arthritis (JIA) remain poorly understood. Social disadvantage may have a cumulative impact on health, with recent analyses using combined scoring systems to measure their impact on outcomes.
Ikechukwu Mbonu, Shannon Tai, Christie M. Bartels, Michael Putman
doi : 10.1002/acr.25036
Geographic disparities in the distribution and practice patterns of rheumatology providers may negatively impact patients with rheumatic diseases
Arif Jetha, Lori Tucker, Faraz Vahid Shahidi, Catherine Backman, Vicki L. Kristman, Elizabeth M. Hazel, Louise Perlin, Laurie Proulx, Cynthia Chen, Monique A. M. Gignac
doi : 10.1002/acr.24982
Workplace and labor market conditions are associated with the health of the working population. A longitudinal study was conducted among young adults with rheumatic disease to examine workplace activity limitations and job insecurity and their relationship with disease symptom trajectories.
Leah Santacroce, Paul F. Dellaripa, Karen H. Costenbader, Jamie Collins, Candace H. Feldman
doi : 10.1002/acr.25015
Climate and social vulnerability contribute to morbidity and health care utilization. We examined associations between the neighborhood Social Vulnerability Index (SVI) and the Heat Vulnerability Index (HVI) and recurrent hospitalizations among individuals with rheumatic conditions.
Alfredo Aguirre, Zara Izadi, Laura Trupin, Kamil E. Barbour, Kurt J. Greenlund, Patti Katz, Cristina Lanata, Lindsey Criswell, Maria Dall'Era, Jinoos Yazdany
doi : 10.1002/acr.24892
Data on the onset of lupus manifestations across multiple organ domains and in diverse populations are limited. The objective was to analyze racial and ethnic differences in the risk of end-organ lupus manifestations following systemic lupus erythematosus (SLE) diagnosis in a multiethnic cohort.
Laura C. Arneson, Kreager A. Taber, Jessica N. Williams, Sciaska N. Ulysse, Daniel L. Erickson, Joan S. Chmiel, Holly Milaeger, Elmer Freeman, Patricia Canessa, Jing Song, Anh H. Chung, Candace H. Feldman, Rosalind Ramsey-Goldman
doi : 10.1002/acr.24889
Clinical trials for systemic lupus erythematosus (“lupus�) under enroll Black individuals despite higher disease prevalence, morbidity, and mortality among Black compared to White individuals.
Manuel F. Ugarte-Gil, Graciela S. Alarcón, Andrea M. Seet, Zara Izadi, Anna D. Montgomery, AlàDuarte-GarcÃÂa, Emily L. Gilbert, Maria O. Valenzuela-Almada, Leanna Wise, Jeffrey A. Sparks, Tiffany Y.-T. Hsu, Kristin M. D'Silva, Naomi J. Patel, Emily Sirotich, Jean W. Liew, Jonathan S. Hausmann, Paul Sufka, Rebecca Grainger, Suleman Bhana, Zachary Wallace, Lindsay Jacobsohn, Anja Strangfeld, Elsa F. Mateus, Kimme L. Hyrich, Laure Gossec, Loreto Carmona, Saskia Lawson-Tovey, Lianne Kearsley-Fleet, Martin Schaefer, Pedro M. Machado, Philip C. Robinson, Milena Gianfrancesco, Jinoos Yazdany
doi : 10.1002/acr.25039
To determine the association between race/ethnicity and COVID-19 outcomes in individuals with systemic lupus erythematosus (SLE).
Tiffany Taylor, Christine Anastasiou, Clairissa Ja, Stephanie Rush, Laura Trupin, Maria Dall'Era, Patricia Katz, Kamil E. Barbour, Kurt J. Greenlund, Jinoos Yazdany, Milena A. Gianfrancesco
doi : 10.1002/acr.24988
Non-White populations are at higher risk of developing systemic lupus erythematosus (SLE) and have more severe outcomes, including mortality. The present study was undertaken to examine how specific causes of death vary by race and ethnicity, including Asian and Hispanic individuals.
Ann Cameron Barr, Megan Clowse, Mithu Maheswaranathan, Lena Eder, Amanda M. Eudy, Lisa G. Criscione-Schreiber, Jennifer L. Rogers, Rebecca E. Sadun, Jayanth Doss, Kai Sun
doi : 10.1002/acr.25030
Medication nonadherence is common among patients with systemic lupus erythematosus (SLE), and adherence often fluctuates with time. Underrepresented racial minorities have disproportionately lower rates of medication adherence and more severe SLE manifestations. We aimed to identify modifiable factors associated with persistent medication nonadherence.
Vanessa L. Kronzer, Hayley J. Dykhoff, Maria A. Stevens, Elena Myasoedova, John M. Davis III, Cynthia S. Crowson
doi : 10.1002/acr.25020
To identify differences in multimorbidity and individual comorbidities among individuals with rheumatoid arthritis (RA), separated by race and ethnicity.
Emma M. Astrike-Davis, Rebecca J. Cleveland, S. Louis Bridges Jr, Beth L. Jonas, Leigh F. Callahan
doi : 10.1002/acr.24896
In prior cross-sectional analyses of African American patients with rheumatoid arthritis (RA), measures of socioeconomic status (SES) were associated with clinical joint damage and poorer patient-reported outcome scores
Oscar Russell, Susan Lester, Rachel J. Black, Catherine L. Hill
doi : 10.1002/acr.25024
Socioeconomic status (SES) influences disease outcomes in rheumatoid arthritis (RA) patients. Differences in medication use may partly explain this association. A scoping review was used to identify research conducted on this topic and determine what knowledge gaps remain.
Megan Thomas, Mark Harrison, Mary A. De Vera
doi : 10.1002/acr.24978
More than ever, it is important to consider inclusion and diversity in rheumatology research. We reviewed and synthesized randomized controlled trials (RCTs) for rheumatoid arthritis (RA) in Canada with the aim of characterizing participants and identifying how determinants of health inequities are reported.
Cristina Fernández-Carballido, Carlos Sanchez-Piedra, Raquel Valls, Kristin Garg, Fernando Sánchez-Alonso, Laura Artigas, José Manuel Mas, Vega JovanÃÂ, Sara Manrique, Cristina Campos, Mercedes Freire, Olga MartÃÂnez-González, Isabel Castrejón, Chiara Perella, Mireia Coma, Irene E. van der Horst-Bruinsma
doi : 10.1002/acr.25048
Real-world studies are needed to identify factors associated with response to biologic therapies in patients with axial spondyloarthritis (SpA). The objective was to assess sex differences in response to tumor necrosis factor inhibitors (TNFi) and to explore possible risk factors associated with TNFi efficacy.
Penny O'Brien, Ryan Prehn, Charmaine Green, Ivan Lin, Wanda Flanagan, Brooke Conley, Dawn Bessarab, Juli Coffin, Peter F. M. Choong, Michelle M. Dowsey, Samantha Bunzli
doi : 10.1002/acr.25004
The aim of this study was to understand and describe the lived experience of Aboriginal and Torres Strait Islander people with osteoarthritis.
George Peat, Dahai Yu, Dorte T. Grønne, Michelle Marshall, Soren T. Skou, Ewa M. Roos
doi : 10.1002/acr.24987
To investigate whether adults with potential multiple social disadvantage have poorer outcomes following attendance in an osteoarthritis (OA) management program (OAMP), and if so, what might determine this result.
Sophie I. E. Liem, Nina M. van Leeuwen, Thea P. M. Vliet Vlieland, Gerrie M. W. Boerrigter, Cornelia H. M. van den Ende, Lian A. J. de Pundert, Marisca R. Schriemer, Julia Spierings, Madelon C. Vonk, Jeska K. de Vries-Bouwstra
doi : 10.1002/acr.24741
To assess the use, satisfaction, needs, and preferences regarding physical therapy (PT) in patients with systemic sclerosis (SSc).
Monica M. Yang, Lauren C. Balmert, Roberta Goncalves Marangoni, Mary Carns, Monique Hinchcliff, Benjamin D. Korman, John Varga
doi : 10.1002/acr.24749
While interstitial lung disease (ILD) is the leading cause of morbidity and mortality in systemic sclerosis (SSc), there remains a paucity of predictive markers to assess disease progression.
Xiurui Zhang, Xiaoxiao Li, Yilin Xiong, Yilun Wang, Jie Wei, Chao Zeng, Tingting Sha, Guanghua Lei
doi : 10.1002/acr.24750
To examine efficacy and safety of tramadol for knee or hip osteoarthritis (OA).
Hylton B. Menz, Michelle Marshall, Martin J. Thomas, Trishna Rathod-Mistry, George M. Peat, Edward Roddy
doi : 10.1002/acr.24754
Hallux valgus is a common and disabling condition. The objective of the present study was to identify factors associated with hallux valgus incidence and progression.
Siobhan M. Case, Candace H. Feldman, Hongshu Guan, Emma Stevens, Laura D. Kubzansky, Karestan C. Koenen, Karen H. Costenbader
doi : 10.1002/acr.24758
We studied posttraumatic stress disorder (PTSD), a severe trauma-related mental disorder, and systemic lupus erythematosus (SLE) risk in a large, diverse population enrolled in Medicaid, a US government-sponsored health insurance program for low-income individuals.
Laura C. Plantinga, Grace Xu, Courtney Hoge, Ann Vandenberg, Charmayne Dunlop-Thomas, Brian D. Jones, Jeremy Johnson, Cristina Drenkard, S. Sam Lim, C. Barrett Bowling
doi : 10.1002/acr.24756
Patient-provider discussions about functioning are often outside the scope of usual care for systemic lupus erythematosus (SLE), and tools to facilitate such discussions are lacking.
Nele Herregods, Robert G. W. Lambert, Eva Schiettecatte, Joke Dehoorne, Thomas Renson, Frederiek Laloo, Thomas Van Den Berghe, Lennart B. O. Jans, Jacob L. Jaremko
doi : 10.1002/acr.24746
To determine prevalence of variations of subchondral bone appearance that may mimic erosions on T1-weighted magnetic resonance imaging (MRI) of pediatric sacroiliac (SI) joints according to age and sex.
Marta Mazzoni, Angela Pistorio, Francesca Magnaguagno, Stefania Viola, Alessia Urru, Gian Michele Magnano, Angelo Ravelli, Clara Malattia
doi : 10.1002/acr.24757
To define the prevalence of subclinical synovitis on magnetic resonance imaging (MRI) in a large cohort of patients with juvenile idiopathic arthritis (JIA) in clinical remission and to evaluate its predictive value in terms of disease flare and joint deterioration.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟